Three glycosyltransferases are involved in tylosin biosynthesis in Streptomyces fradiae. The first sugar to be added to the polyketide aglycone (tylactone) is mycaminose and the gene encoding mycaminosyltransferase is oH2* (tyhW2). However, targeted disruption of od2* did not lead to the accumulation of tylactone under conditions that normally favour tylosin production; instead, the synthesis of tylactone was virtually abolished. This may, in part, have resulted from a polar effect on the expression of genes downstream of oH2*, particularly od4* (ccr) which encodes crotonyl-CoA reductase, an enzyme that supplies 4-carbon extender units for polyketide metabolism. However, that cannot be the entire explanation, since tylosin production was restored a t about 10% of the wild-type level when oH2* was re-introduced into the disrupted strain. When glycosylated precursors of tylosin were fed to the disrupted strain, they were converted to tylosin, confirming that two of the three glycosyltransferase activities associated with tylosin biosynthesis were still intact. Interestingly, however, tylactone also accumulated under such conditions and, to a much lesser extent, when tylosin was added to similar fermentations. It is concluded that glycosylated macrolides exert a pronounced positive effect on polyketide metabolism in S. fradiae.
INTRODUCTION
The macrolide antibiotic, tylosin (Fig. l ) , is produced by Streptomyces fradiae via a combination of polyketide and 6-deoxyhexose metabolism. Glycosylation of tylactone, the cyclized polyketide product, always begins with the addition of mycaminose followed, in a preferred but not obligatory order, by deoxyallose and then mycarose to generate demethyl-macrocin. Stepwise bis 0-methylation then converts the deoxyallose moiety to mycinose as macrocin is produced and converted to tylosin (Baltz et al., 1983) . Characterization of the tylosin biosynthetic pathway (Fig. 2) was facilitated by the availability of non-producing mutants of S. fradiae, generated using NTG (Baltz & Seno, 1981) . Collectively, these exhibited nine distinct phenotypes in cross-feeding Abbreviations: OMT, 0-mycaminosyl-tylonolide; DMT, demycinosyltyl osi n. The biosynthetic route from tylactone to tylosin. The preferred pathway from OMT to tylosin (solid arrows) goes via demethyl-lactenocin and demethyl-macrocin (Baltz et a/., 1983) . However, this route is not obligatory since DMT and desmycosin accumulate in blocked mutants of 5. fradiae and can be bioconverted to tylosin (dashed arrows). The step a t which various ty/ mutations block the pathway is indicated. 1989; Fishman et al., 1987) . Sequence analysis of DNA spanning the tylLM loci (Gandecha et al., 1997) revealed four located between the terminal thioesterase gene of the tylG polyketide synthase cluster and the resistance determinant, tlrD (Fig. 3 ) . The function of the Orfl':. protein is not known, but the deduced products of the other three genes displayed convincing similarities to authentic enzymes in end-toend sequence comparisons. Thus, the orf2:' product is a glycosyltransferase, the Orf3':-protein is a methyltransferase and orf4" encodes crotonyl-CoA reductase. The latter appears to be an ancillary gene, ostensibly recruited into the tyl cluster to provide butyryl-CoA for polyketide metabolism. Sequence analysis of o?f? in S. fradiae GS62 (a tylM mutant defective in mycaminose metabolism), revealed an amino acid substitution in the presumed cofactor binding site of the enzyme, and reintroduction of orf3'-into this organism resulted in restoration of tylosin biosynthesis (Gandecha et al., 1997) . However, orf2'-and its product were less easy to characterize. A tylL mutant, S. fradiae GS33 (unable to synthesize or add any of the three tylosin sugars), harbours a single mutational change (a GC to AT transition) in orf2"-that generates an in-frame stop codon early in the coding sequence (Clark, 1997) . However, attempts to restore tylosin production in this strain by complementation with fragments of tylLM DNA were inconclusive, suggesting that the TylL phenotype probably results from multiple mutations.
We therefore generated a strain of S. fradiae specifically disrupted in orf2" in a further attempt to characterize the action of Orf2". Unexpectedly, polyketide metabolism was also affected in this strain.
Bacterial strains and plasmids. S. fradiae T59235 (also known as C373.1; referred to here as wild-type) and derivatives thereof were routinely grown at 30 "C in Tryptic Soy Broth (TSB; Difco) or at 37 "C on AS-1 agar plates (Baltz, 1980) and were maintained at -70 "C as mycelial fragments following addition of 5% (v/v) DMSO (final concn) to TSB-grown cultures. tyl DNA (11 kb) from S. fradiae was initially excised from cosmid pMOMT4 (Beckmann et al., 1989) and introduced into pUC18 to generate pLST97 (Gandecha et al., 1997) from which an 8 kb KpnI-BamHI fragment spanning the tylLM loci was excised and subcloned, again in pUC18, to generate pLST97A. This contained tyl orfs I'>-P:' plus tlrD and the terminal portion of tylG (see Fig. 3 ). pUC-derived plasmids were manipulated in Escherichia coli using standard protocols (Sambrook et al., 1989) .
Construction of disrupted orf2*. PCR-amplified orf2" (1.4 kb), with engineered terminal BamHI and PstI sites, was generated using the following primers : 5' GGATCCGTGC-GTCGTGCACTGGATGAC 3' and 5' CTGCAGCTACC-TTTCCGGCGCGGATCG 3'. Reaction mixtures (50 pl) were specifically designed for G + C-rich DNA templates and contained 50 ng template (pLST97A), 250 ng each primer, 1 mM dNTPs and 1 U T a q DNA polymerase in buffer containing 60 mM Tris/HCl, pH 8.5 (adjusted at 20 "C), 3.5 mM MgCI,, 15 mM (NH,)2S0, and 10 YO DMSO. After an initial hot start at 80 "C for 5 min, the mixture was subjected to 35 cycles of amplification, each consisting of 1 min at 94 "C, 2 min at 60 "C and 3 min at 72 "C, before the thermal cycle was terminated with 7 min at 72 "C. The PCR product was captured in pGEM-T (Promega) and introduced into E. coli NM522 (Gough & Murray, 1983) . orf2':' was excised from the plasmid using the terminal BamHI and PstI sites, ligated into the respective sites in pRSET A (Invitrogen) and disrupted at the unique (and slightly off-centre) AatII site by insertion of the 2.3 kb hygromycin-resistance cassette, Qhyg (BlondeletRoualt et al., 1997) . This involved blunt-end ligation using the Boehringer Mannheim Rapid DNA Ligation Kit following treatment of linearized plasmid with mung bean nuclease (Promega). Disrupted orf2" (3.7 kb) was then removed by digestion with NheI and PstI and ligated into pOJ260, which cannot replicate in actinomycetes (Bierman et al., 1992) . The resultant plasmid (pLST9734) was initially propagated in E. coli NM522, before being introduced into E. coli S17-1, the donor strain used for conjugal transfer to Streptomyces spp. (modified from Bierman et al., 1992; Mazodier et al., 1989) .
Targeted disruption of orf2* in 5. fradiae. Following growth of S. fradiae C373.1 on AS-1 medium at 37 "C for 3 d, spores from one plate were resuspended in 10 ml pre-germination medium (Hopwood et al., 1985) and incubated at 37 "C for 3-4 h before centrifugation and resuspension in 500 pI LB broth. An overnight culture (5 ml) of E. coli S17-1 (containing pLST9734) grown in LB medium containing spectinomycin (30 pg ml-l ; Sigma) and apramycin (25 pg ml-l ; Lilly Research Laboratories) was harvested and resuspended in 500 p1 LB medium. Then 200 p1 of the germinating spore suspension was mixed with 100 p1 of the E. coli donor cells, plated onto AS-1 agar and incubated at 37 "C. After 18 h, the plate was overlaid with 4ml soft R2 agar (Hopwood et at., 1985) containing hygromycin B (100 pg ml-l ; Calbiochem) to select for transconjugants and nalidixic acid (60 pg ml-'; Sigma), to inhibit donor cell growth, and incubation was continued at 37 "C for 7 d or until colonies had grown through the overlay. Colonies were picked and dually inoculated onto AS-1 medium containing hygromycin B (100 pg ml-') or apramycin (25 pg ml-') to screen for recombinants containing double cross-overs in which chromosomal orf2':' had been replaced with the disrupted gene. Such strains were expected to be hygromycinresistant and apramycin-sensitive. Southern blot hybridization analysis was used to confirm the gene replacement and one such strain, SFO1, was chosen for further analysis.
Complementation of strain SFO1 with PCR-amplified orf2*.
PCR-amplified 0rf2:~ was ligated into the BamHI site of pLST9829, a low-copy-number replicating plasmid (A. R.
Butler & E. Cundliffe, unpublished) , downstream of the strong, constitutive promoter ermEp" (Bibb et al., 1994) . The resultant plasmid, pLST9735, was then introduced into S. fradiae SFOl by conjugal transfer from E. coli S17-1, thereby generating strain SF02.
Tylosin-production fermentation. Conical flasks (100 ml capacity) containing 25 ml pre-fermentation medium were inoculated with 100 pl S. fradiae stock mycelial fragments and incubated at 28 "C with rotary shaking at 300 r.p.m. for 3 d (wild-type and strain SFO1) or 5 d (strain SF02, grown in the presence of apramycin, see below). Pre-fermentation medium (pH adjusted to 7.8 with NaOH) contained 1 % (w/v) corn steep liquor, 0.5 '/o (w/v) yeast extract, 0.5 '/O (w/v) soya bean meal, 0.3% (w/v) calcium carbonate and 0.5% (v/v) methyl oleate. Then 5 ml portions of each culture were used to inoculate 45 ml batches of MM-1 tylosin production medium (Gray & Bhuwapathanapun, 1980) and incubation was continued under similar conditions for a further 7 d. [To maintain pLST9735 in strain SF02, apramycin (25 pg ml-l) was added to batches of pre-fermentation medium and tylosin production medium used for this strain.] Fermentation products were extracted by shaking the entire culture with an equal volume of chloroform, the extracts were dried by rotary flash evaporation at 30 "C and the residues re-dissolved in 500 pl HPLC grade chloroform.
Analysis of fermentation products. This was done by reverse phase HPLC (as described by Huber et al., 1990 ) using a 3.9 x 300 mm C18 pBondapak column protected by a C18 pBondapak guard column (Waters Associates). Chloroform extracts were applied to the column in 0.3% (w/v) ammonium formate (pH 4.0) containing 50 '/o (v/v) methanol and products were eluted using a similar buffer with a linear concentration gradient (50-80 YO) of methanol at a flow rate of 1.75 ml min-l. The absorbance of the eluate was monitored at 282 nm. O-Mycaminosyl-tylonolide (OMT), demycinosyl-tylosin (DMT), demycarosyl-tylosin (desmycosin) and tylosin (10 mg each) were added separately to fermentation cultures (50 ml) in MM-1 medium after 2 d at 28 "C and incubation was continued for a further 3 d prior to extraction with chloroform and HPLC analysis of the products, as above.
RESULTS AND DISCUSSION
The glycosyltransferase sequence motif When orf2" was first sequenced, its deduced product was suggested to be a glycosyltransferase (Gandecha et al., 1997 ducing Amycolatopsis orientalis, displayed glucosyltransferase activity with a glycopeptide-aglycone as acceptor substrate (Solenberg et al., 1997) . Other entries in the protein identification databases were also found in routine searches using the Orf2'" sequence, including DnrS and DauH from daunorubicin (daunomycin)-producing S. peucetius (Otten et al., 1995) and Streptomyces sp. strain C5 (Dickens et al., 1996) , respectively, but the closest match (50 % identity) was found with the product of eryCZIl (orf8) from the erythromycin producer, Saccharopolyspora erythraea (Haydock, 1992) . These proteins all contain a consensus sequence motif (Fig. 4) that is also present in eukaryotic enzymes and appears to be diagnostic of a sub-group of glycosyltransferases (Cundliffe et at., 1997) , although it is not present in all such enzymes. This sequence motif has been used to design (by reverse genetics) deoxyoligonucleotides that find specific hybridization targets in the genomes of antibiotic-producing Streptomyces spp. (A. R. Gandecha & E. Cundliffe, unpublished data). The location of orf2" within the tylosin biosynthetic (tyl) gene cluster of S. fradiae suggested that it probably encoded one of the three glycosyltransferase activities involved in tylosin production. This hypothesis was addressed by a combination of gene disruption and bioconversion studies.
Targeted disruption of orf2* via gene replacement
Initially, 0~f2:' was amplified by PCR from wild-type tyl DNA and disrupted by insertion of the hygromycin B-resistance cassette, Qhyg (Blondelet-Roualt et al., 1997) . The disrupted orf2:' was then ligated into pOJ260, a suicide vector unable to replicate in actinomycetes (Bierman et al., 1992) , and introduced into S. fradiae via conjugal transfer from E. coli S17-1. Hygromycin B-resistant transconjugants that lacked the apramycin-resistance gene of PO 5260 were selected phenotypically and Southern blot hybridization analysis (data not shown) confirmed that one such strain (designated SFO1) had undergone double recombination, resulting in replacement of chromosomal orf2" by the disrupted gene. Thus, using orf2'" as probe, the hybridization target in AflIII digests of the SFOl genome was increased in size compared with that in the wildtype (6.9 vs 4.6 kb) and was also found by an Qhyg probe. However, strain SFOl had lost the remainder of PO J260, including the apramycin-resistance gene. In negative controls, genomic DNA from S. fradiae wildtype did not light up with the Qhyg probe or with the apramycin resistance gene.
Fermentation and bioconversion analysis
The fermentation products of S. fradiae wild-type and strain SFOl were compared by reverse phase HPLC, following 7 d incubation at 28 "C in tylosin production medium. As expected, the wild-type produced tylosin (Fig. 5a ) but, surprisingly, strain SFOl produced very little material that absorbed at 282 nm (Fig. 5b) although traces of tylactone could be detected when the sensitivity of analysis was increased 100-fold (data not shown). In contrast, no glycosylated precursors of tylosin were evident. However, when glycosylated macrolides were fed to strain SFOl during similar fermentations, O M T was converted to tylosin (Fig. 5d) , as were D M T and desmycosin, revealing that strain SFOl still possesses the deoxyallosyl-and mycarosyl-transferase activities normally associated with tylosin biosynthesis. When PCRamplified orf2", governed by the strong, constitutive ermEp" promoter (Bibb et al., 1994) , was re-introduced into strain SFOl using pLST9735 to generate strain SF02, tylosin production was restored but only at about 10 % of the wild-type level (Fig. 5f ).
In rationalizing these results, we considered the proposition that orf2'' encodes a glycosyltransferase to be secure. The level of similarity between its deduced product and authentic glycosyltransferases, such as the GtfB protein, renders other possibilities remote. Since mycaminose is normally the first sugar to be added to the polyketide aglycone during tylosin production and since glycosylated macrolide(s) are not produced by the orf2"-disrupted strain, SFO1, we conclude that 0rf2" encodes the mycaminosyl-transferase enzyme. Accordingly, orf2:> has been designated tylM2 since it is located at, or very close to, the mycaminose-specific tylM locus in the genome of S. fradiae (Beckmann et al., 1989; Fishman et al., 1987) . Why then does strain SFOl not accumulate significant levels of tylactone ? Is tylactone unstable in S. fradiae when not glycosylated, or is polyketide metabolism impaired in strain SFOl ?
Polyketide metabolism and glycosylation
These results call to mind earlier observations with the tylM mutant, GS62, in which orf3:' has recently been shown to be altered (Gandecha et al., 1997) . This Tylosin production in Streptomyces fradiae lated only trace amounts of tylactone, together with fatty acids of intermediate chain length that appeared to be precursors of tylactone rather than degradation products (Huber et al., 1990) . Similar products were also seen with other S. fradiae mutants, including a tylB mutant (blocked in mycaminose biosynthesis) and t y l A and tylL mutants (blocked in the biosynthesis or addition of all three tylosin sugars), but strains blocked beyond O M T in the tylosin biosynthetic pathway (see Fig. 2 ) accumulated the expected glycosylated intermediates. Those results (Huber et al., 1990 ) and the present data suggest that polyketide metabolism in S. fradiae is impaired when the primary product, tylactone, cannot be glycosylated. Interestingly, tylactone did accumulate (together with unidentified material eluting slightly earlier during HPLC) in strain SFOl when tylosin or its glycosylated precursors were added to fermentations. This effect (Fig. Sd) was seen most prominently with OMT, and also with DMT or desmycosin (for structures, see Fig. 2 ) , whereas, of the four compounds tested, tylosin was by far the least active in this respect (Fig. 5e ). Since tylactone could not have been formed by degradation of the added compounds (unless, as seems unlikely, lactone ring hydroxylation could be reversed), polyketide metabolism appears to have been stimulated in the presence of the glycosylated macrolides.
Superimposed on such considerations is the possibility that disruption of 0rf2'~ in strain SFOl might have exerted a polar effect on the expression of downstream genes, particularly orf4':-(ccr) which encodes crotonylCoA reductase. This enzyme has been proposed (Gandecha et al., 1997) to participate in the conversion of acetoacetyl-CoA to butyryl-CoA, the extender unit that provides carbons 5,6,19 and 20 of tylactone during polyketide metabolism, although other (perhaps less productive) routes to butyryl-CoA are not excluded.
Whether the failure of strain SFOl to accumulate tylactone and/or the low level of tylosin production by strain SF02 are due to impaired expression of ccr may become clear when transcripts have been mapped and promoters located within the orfZ'--4" region. It is also possible that the performance of strain SF02 may have been adversely influenced by the state of the PCRamplified o r f 2 construct, which was not sequenced. Studies are in hand to assess these various possibilities together with the likely contributions of genetic regulatory elements to the control of polyketide and/or deoxyhexose metabolism in S. fradiae.
